Jorge Quiroz

May 22, 2024 | dialnet.unirioja.es | Jorge Quiroz |Rómulo A. Chumacero

IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână

Mar 22, 2024 | neurologylive.com | Jorge Quiroz

WATCH TIME: 5 minutes"Because we’re at a proof-of-concept stage, we’ve decided to focus on this very homogenous population. This was based on our opinion and the opinion of other experts in the field.

Mar 5, 2024 | neurologylive.com | Jorge Quiroz

WATCH TIME: 4 minutes"We think that NMD 670, if therapeutically beneficial, could be utilized alone, or in combination therapy with previously approved medications. Because of the maximum faction, it will be efficacious by itself."In recent years, the treatment landscape for patients with spinal muscular atrophy (SMA), a rare devastating neuromuscular disorder, has expanded, with 3 approved medications.

Feb 20, 2024 | aiche.onlinelibrary.wiley.com | Xiaoyan Tang |Jorge Quiroz |Yixiao Zhang |Jessica Pan

CONFLICT OF INTEREST STATEMENT All authors are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ USA. REFERENCES 1, , . CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012; 93(3): 917-930. 2, . A review on the current methods of Chinese hamster ovary (CHO) cells cultivation for the production of therapeutic protein. Curr Drug Discov Technol. 2021; 18(3): 354-364. 3, .

Feb 20, 2024 | aiche.onlinelibrary.wiley.com | Xiaoyan Tang |Jorge Quiroz |Yixiao Zhang |Jessica Pan

CONFLICT OF INTEREST STATEMENT All authors are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ USA. REFERENCES 1, , . CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012; 93(3): 917-930. 2, . A review on the current methods of Chinese hamster ovary (CHO) cells cultivation for the production of therapeutic protein. Curr Drug Discov Technol. 2021; 18(3): 354-364. 3, .